Ratiometric Bioluminescent Indicator for Simple and Rapid Diagnosis of Bilirubin

Yukino Itoh1, Mitsuru Hattori2, Tetsuichi Wazawa2

  • 1Graduate School of Frontier Biosciences, Osaka University, 2-1 Yamadaoka, Suita 565-0871, Japan.

ACS Sensors
|January 14, 2021
PubMed

Insights

A new bioluminescent indicator, BABI, enables sensitive detection of unconjugated bilirubin (UCBR) in blood. This method offers a simple, rapid smartphone-based assay for diagnosing jaundice and related conditions.

Area of Science:

  • Biochemistry
  • Medical Diagnostics
  • Biotechnology

Background:

  • Bilirubin levels in blood are crucial indicators of health, with unconjugated bilirubin (UCBR) elevation linked to neonatal jaundice.
  • Neonatal jaundice can lead to severe complications like kernicterus and hearing loss, necessitating frequent monitoring.
  • Current methods for UCBR measurement can be complex and require specialized equipment.

Purpose of the Study:

  • To develop a novel ratiometric bioluminescent indicator for sensitive and quantitative detection of UCBR.
  • To establish a rapid and accessible assay for UCBR measurement using a smartphone.
  • To provide a tool for early diagnosis and management of conditions associated with high UCBR levels.

Main Methods:

  • Development of a ratiometric bioluminescent indicator, BABI, which shifts emission color based on UCBR concentration.
  • Utilizing bioluminescence for high signal-to-noise ratio detection, surpassing absorption and fluorescence methods.
  • Employing a smartphone camera for quantitative analysis of UCBR in small blood samples.

Main Results:

  • BABI demonstrates a color change from blue to green correlating with UCBR concentration.
  • The bioluminescent assay achieves high sensitivity and quantitative accuracy for UCBR detection.
  • The system allows for rapid UCBR assessment using minimal blood volume.

Conclusions:

  • BABI provides a sensitive, quantitative, and user-friendly method for UCBR assessment.
  • The smartphone-based platform enables accessible point-of-care diagnostics for jaundice.
  • This bioluminescent indicator assay represents a significant advancement in blood-based diagnostics.

Related Concept Videos